Bacteria save energy by producing proteins that moonlight, having different roles at different times, which may also protect the microbes from being killed. The moonlighting activity of one enzyme from the tuberculosis bacterium makes it partially resistant to a family of broad-spectrum antibiotics, according to a paper published in the September issue of the journal Microbiology.

"Glutamate racemase, or MurI, is an enzyme that bacteria use to make the building blocks of cell walls," said Professor Valakunja Nagaraja from the Indian Institute of Science in Bangalore, India. "MurI from Mycobacterium tuberculosis also stops the enzyme DNA gyrase from working, which in turn stops DNA replication and cell division."

The researchers found that the two different functions work independently of one another - the enzyme's ability to make cell wall components does not affect its ability to inhibit DNA gyrase and vice versa.

CALGARY, Canada, September 2 /PRNewswire/ --

<< 50 Per Cent Interest and Operator of Gryphon Marin License Area, Adjacent to Existing Operations Offshore Gabon >>

Canada Addax Petroleum Corporation ("Addax Petroleum" or the "Corporation") (TSX:AXC and LSE:AXC), today announced that it has acquired a 50 per cent interest in the Gryphon Marin license area subject to final Government of Gabon approval. Addax Petroleum will become operator of the Gryphon Marin license area which is immediately west of the Corporation's Iris Marin and Ibekelia license areas and immediately north of the Corporation's Etame Marin license, offshore Gabon.

CARLSBAD, California, September 2 /PRNewswire/ --

- Important Studies Presented at the European Society of Cardiology Continue to Bring Attention to Innovative Technology

Ablation Frontiers, Inc., announced today that two important studies, involving its innovative atrial fibrillation ablation products were presented by Dr. Lucas Boersma of the St. Antonius Hospital in Nieuwegein, Netherlands at the European Society of Cardiology (ESC) congress. One of the world's most prestigious scientific meetings for cardiologists, the ESC meetings took place from August 30 - September 3 in Munich, Germany.

CALGARY, Canada, September 2 /PRNewswire/ --

- Multiple Presentations Included Resverlogix Data

- TSX Exchange Symbol: RVX

SAN RAMON, California, September 2 /PRNewswire/ --

Achievo(R) Corporation, a software outsourcing and information technology services provider, is proud to announce it is working with The InnoVest Group, LC, a US based management consulting and joint venture firm, to provide IT outsourcing (ITO) services and solutions in the Middle East, initially in Saudi Arabia, UAE, Bahrain, and Jordan. Achievo offers its clients local account management and project delivery capabilities through its regional offices in Japan, North America, Europe and Greater China that are integrated with and supported by its offshore delivery centers in China and its headquarters in the United States.

WELLESLEY HILLS, Massachusetts, September 2 /PRNewswire/ --

Joseph F. Finn, Jr., C.P.A. ("Finn"), Assignee of the assets of Spherics, Inc. ("Spherics") for the benefit of creditors, announced today that all pharmaceutical intellectual property will be sold at a sealed bid auction on October 10, 2008.

With SRx-503, Spherics has developed an improved version of a first and second line treatment for Parkinson's disease. Current global sales exceed US$700 million (approx. US$600 million US only), despite a severe side-effect profile (including motor fluctuations and GI and CNS AE's) and compliance issues (3x daily dosing). SRx-503 maintains a more stable release profile, bypasses the stomach to alleviate GI side effects and requires dosing only once daily.

MUNICH - ESC Congress 2008, September 2 /PRNewswire/ --

- Presented at the Annual ESC Congress 2008, Munich, Germany, 31 August 2008

For the first time, results from a new landmark trial of purified n-3 polyunsaturated fatty acids (n-3 PUFAs) were presented at one of the worlds' largest cardiology meetings by Professor Luigi Tavazzi (GISSI-HF): n-3 PUFAs reduced mortality and hospital admissions for cardiovascular reasons in patients with symptomatic heart failure(1).

KIEV, September 2 /PRNewswire/ -- Lugansk Energy Interconnection Company LLC, one of the five largest electrical energy suppliers in Ukraine, a part of the Energy Standard Group, reports that it has received permission from the Ukrainian Anti-Monopoly Committee to purchase more than 50% of Teploelectrotsentral-3 CJSC (TEC-3), Kharkov, Ukraine. TEC-3, in an oblast (province) adjacent to Lugansk, is one of Ukraine's largest producers of heating and electrical energy, with annual production capacity of 100 Megawatts. Kharkov, in northeastern Ukraine, is the nation's second largest city, with a population of 1.5 million.

ANN ARBOR, Michigan, September 2 /PRNewswire/ --

Terumo Cardiovascular Systems (Terumo CVS) announced that it filed a patent infringement complaint on August 21 in the Northern District of California against Maquet Cardiovascular LLC. The complaint alleges that Maquet's Vasoview(R) Endoscopic Vessel Harvesting Systems infringe a patent for which Terumo CVS owns the rights. The complaint also requests an injunction against further sales of the product in the U.S.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061027/DEF004LOGO )

Terumo CVS sells the VirtuoSaph(TM) Endoscopic Vessel Harvesting System in the United States. The VirtuoSaph system is distributed in Japan and Asia by Terumo Corporation and in Europe by Terumo's European subsidiary.

ATLANTA, September 2 /PRNewswire/ --

**Transaction Combines Innovators in OTC Products and Services** **Investor Call Scheduled for September 12**

IntercontinentalExchange (NYSE: ICE), a leading operator of regulated global derivatives exchanges and over-the-counter (OTC) markets, announced the completion of its acquisition of Creditex Group Inc. (Creditex), a leader in trade execution and processing of credit default swaps (CDS) in markets spanning the U.S., Europe and Asia. The acquisition was completed on August 29, 2008. ICE expects to file a Current Report on Form 8-K, which will include Creditex's financial information and pro forma financial information, with the Securities and Exchange Commission prior to the close of business today.